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Abstract 
Background The long term benefits of exercise on the cardiovascular status of a patient 
have been proven, however, their benefit/risk relationship with exercise intensity is unclear. 
Furthermore, many thromboembolic diseases such as myocardial infarction and ischaemic 
stroke are associated with profound catecholamine release. In this study we explore the 
relationship between catecholamine release and hemodynamic changes and their effect on 
coagulation.   
Materials and Methods Twelve healthy recreationally active males were recruited. Local 
anaesthesia was given and catheters were placed under aseptic conditions, in the femoral 
artery and vein of the experimental leg. The first experiment involved tyramine infusion into 
the femoral artery at a dose of 1.0 µmol · min-1 · L leg volume-1. The second experiment 
involved single leg knee-extensor exercise performed at 30 W for 15 min. Venous blood was 
collected at each time point to assess clot microstructure using the df biomarker. 
Results and Conclusions Tyramine infusion causes a local noradrenaline release in the leg. 
The increase in noradrenaline was associated with a significant increase in clot 
microstructure formation (df increased from 1.692±0.029 to 1.722±0.047,p=0.016). 
Additionally moderate intensity single leg knee extensor exercise, which minimally alters 
sympathetic activity, also induced an increases in df (from 1.688±0.025 to 1.723±0.023, 
p=0.001). This suggests that exercise can alter clot microstructure formation both via an 
increase in catecholeamine levels and by factors related to muscle activity per se, such as 
increased blood flow and consequent shear. These findings have implications for 
recommendations of exercise in patients at risk of cardiovascular events.  
Keywords: catecholamine, clot microstructure, coagulation, exercise 
  
Highlights 
•  Exercise and thromboembolic diseases are associated with profound 
catecholamine release 
•  In this study we show for the first time how catecholamine release and exercise 
alters coagulation 
• Both moderate exercise and catecholamine produce denser/compact clot 
microstructures 
• These findings have implications for recommendations of exercise in patients at 
risk of cardiovascular events. 
  
Introduction 
High intensity exercise induces physiological changes such as increases in skeletal muscle 
blood flow, altered blood volume distribution and shear stress blood profile as well as 
platelet reactivity.[1,2] All of which have been shown to be driving factors for 
hypercoagulability in healthy people  performing exercise.[3,4] Accordingly,  a previous 
study on exercise in healthy volunteers demonstrated that hypercoagulability was 
associated with exercise intensity.[5]   
The hemodynamic changes that occur with exercise are controlled by the autonomic 
nervous system which increases both cardiac output and systemic vascular resistance. In the 
working muscle, the vasoconstriction is potently overruled by locally formed sympatholytic 
and vasodilator compounds, leading to marked increases in local blood flow and oxygen 
supply and demand.[6] The extent of the sympathetic drive is related both to exercise 
intensity and the size of muscle mass involved in the exercise.[7] The hypercoagulable state 
induced by exercise shown in previous studies [5,8] may therefore be associated, not only 
with the change in shear profile, but also with an increase in plasma catecholamine 
(norepinephrine) levels. The specific roles of shear profile and catecholamine release in 
exercise induced hypercoagulability have not been examined.  
The roles of catecholamines and hemodynamic changes are important for two reasons: 
firstly, although the long term benefits of exercise on the cardiovascular status of a patient 
have been proven, their benefit/risk relationship with exercise intensity is unclear. A 
particular concern here could be the more widespread use of high intensity exercise which 
leads to high plasma catecholeamine levels and potentially an acute increased risk of blood 
clot formation. [5] Secondly, many thromboembolic diseases such as myocardial infarction 
and ischaemic stroke are associated with profound catecholamine release.[9,10] 
Thromboembolic disease is also strongly associated with altered blood flow and altered 
shear patterns due to underlying vascular endothelial damage and obstruction which are 
known to affect outcome and thromboembolic risk.[11,12] Furthermore, rehabilitation of 
the patient often involves a graded and prolonged exercise program to improve cardiac 
function and coronary blood flow. Therefore the exercise regime prescribed to cardiac 
patients, who may already have a compromised coagulation system, may place them in an 
unfavourable risk / benefit ratio.  
In this study we explore the relationship between blood flow, shear stress, catecholamine 
release and coagulation in the human leg vasculature. We aim to use a biomarker of clot 
microstructure, fractal dimension at the Gel point, df, to evaluate these relationships.[13] 
We have chosen to investigate clot microstructure, as it has been shown to be of critical 
importance in the quality of the clot that is formed during coagulation and plays a vital role 
in pathophysiology and outcome of cardiovascular and thromboembolic disease.[14-17] 
How the microstructure of the clot is organised governs its mechanical properties and 
controls the rate of fibrinolysis.[15,18] The clot microstructure biomarker df has previously 
been successfully used to measure the effect on coagulation of several diseases; 
anticoagulation/antiplatelet treatment and high intensity exercise.[5,19-22] In the present 
study we performed two experiments in young healthy men. The first involved local infusion 
of tyramine to induce the release norepinephrine. The second involved single leg knee 
extensor exercise, engaging only a small muscle mass and with a consequent low degree of 
sympathetic drive. Clot microstructure, coagulation factors, noradrenaline and 
hemodynamic changes were assessed to explore the specific role of catecholamines and 
blood flow/shear in changing coagulation and clot microstructure formation.  
  
Methods 
Twelve healthy recreationally active males were recruited to participate in the study (Age: 
23.1±3.2yrs; Height: 185±7cm; Weight: 80.7±9.3kg; VO2MAX: 4151±554mL/min and BMI: 
1.85±0.07). The subjects underwent an initial screening consisting of: a medical 
examination; 12-lead electrocardiogram (ECG); and venous blood sampling for health 
related parameters. Exclusion criteria were history or symptoms of cardiovascular disease, 
renal dysfunction, insulin resistance, diabetes, or hypercholesterolemia, recent (<3 years) 
history of smoking and intake of prescription medicine. In addition, the participants 
performed an incremental bicycle ergometer exercise test to determine pulmonary 
V ̇O2max (L min-1) (Oxycon Pro, Intramedic, Denmark). The study was approved by the 
Ethics Committee of the Capital Region of Copenhagen (H-15014050) and conducted in 
accordance with the guidelines of the Declaration of Helsinki. Written informed consent was 
obtained from all subjects before enrollment into the study. 
Experimental protocol 
The participants (n=12) were instructed not to ingest caffeine, alcohol, or to exercise for 24 
h before each experimental day and to eat their regular breakfast. After a short rest in the 
supine position, local anesthesia (lidocaine, 20 mg/ml; Astra Zeneca, Denmark) was given 
and catheters (20 G; Arrow, Reading, PA) were placed under aseptic conditions, in the 
femoral artery and vein of the experimental leg 2 cm below the inguinal ligament. A three-
port connector was placed in series so that infusion and blood pressure measurements 
could be performed simultaneously. Arterial and venous pressures were monitored by 
transducers positioned in the femoral artery and vein (Pressure monitoring it, Baxter, IL, 
USA). Leg vascular conductance was calculated from perfusion pressure (femoral arterial –
femoral venous pressure) and blood flow. 
Effect of elevated noradrenaline levels on clot structure: Tyramine (Sigma Aldrich, St. Louis, 
MO, USA) was infused into the femoral artery for 3 min at a dose of 1.0 µmol · min-1 · L leg 
volume-1 with participants in supine position. Femoral arterial blood flow, intra-arterial and 
venous blood pressure were determined and venous and arterial blood samples were 
obtained prior to and during the last minute of infusion. Tyramine evokes norepinephrine 
release from neuronal vesicles and consequent release of norepinephrine out of nerve 
terminals. [23] 10 ml of venous blood was collected before and after tyramine infusion. Each 
blood sample was divided into several aliquots. One aliquot of whole venous blood was 
immediately transferred and used for viscoelastic measurements. The remaining aliquots 
were used to perform standard coagulation screens and noradrenaline concentration. 
Effect of exercise with a small muscle mass on clot structure. After 30 min of rest, the 
participants were seated in a semi-recumbent position with the hip-angle fixed at ~120°. 
Knee-extensor exercise was performed with the experimental leg at 30 W and a frequency 
of 60 extensions per minute. The workload was sustained for 15 min. Venous and arterial 
blood samples were drawn prior to and at the end of the exercise session. 10 ml of venous 
and arterial blood was collected before and after the exercise program. Each blood sample 
was divided into several aliquots. One aliquot of whole venous and whole arterial blood was 
immediately transferred and used for viscoelastic measurements. The remaining aliquots 
were used to perform standard coagulation screens.  
Blood tests 
Viscoelastic Measurements: The viscoelastic measurements are based on attainment of the 
Gel Point (GP) from which the fractal dimension, df, is determined. The GP technique has 
been previously validated for use with blood in several studies.[5,19-22] Briefly, blood is 
placed within the double concentric measuring geometry of a controlled stress rheometer, 
AR-G2 (TA Instruments, New Castle, DE, USA) which is held a constant temperature of 37°C 
± 0.1ºC. Immediately after loading the blood into the AR-G2, viscoelastic analysis is 
preformed using small amplitude oscillatory shear measurements at varying frequencies; 2, 
0.93, 0.43 and 0.2Hz, with an applied peak stress amplitude of 0.03Pa. Repeatedly 
performing these measurements over time allows for the measurement of the GP.  The GP 
marks the transition of the blood from a visco-elastic liquid to a visco-elastic solid, where 
the GP identifies the formation of the incipient blood clot or the first point which a sample 
spanning (haemostatic) structure can be identified. From the GP measurement we can 
quantify how the fibrin clot is organised by calculating its corresponding fractal dimension, 
df, clotting time (tgel) and the elastic properties of the incipient clot (G`GP). 
Standard laboratory markers: A 3 ml aliquot of blood was drawn into the 3.2% sodium 
citrate vacutainers (Greiner Bio-One GmbH, Austria, REF: 454327) to assess standard 
coagulation markers: Prothrombin Time (PT), activated partial thromboplastin time (aPTT) 
and Clauss fibrinogen. The standard coagulation markers were measured using a ACL TOP 
750 cts Analyser by standard methods at The Department of Clinical Biochemistry, 
Rigshospitalet, Denmark.  
Analysis of noradrenaline: A 2ml aliquot of blood was used to measure the plasma 
noradrenaline concentrations were determined with an immunoassay (Noradrenaline ELISA 
Fast Track, LDN, Nordhorn, Germany) according to the manufactures protocol. 
Statistical Analysis: Differences between groups were compared using two sample t-tests 
for parametric data. Pearson correlation was undertaken to explore associations between df 
and physiological parameters, laboratory markers and platelet aggregometry. Statistical 
analysis was performed using Minitab version 15 software (Havertown, PA, USA) and 
deemed significant when p< 0.05. 
  
Results  
The characteristics of the participants are shown in table 1. 
Effect of elevated noradrenaline levels on clot structure: With tyramine infusion, the df 
value increased from 1.692±0.029 at baseline to 1.722±0.047 (p=0.016). There was no 
significant change in the clotting time measurement of the GP (TGP) (237±56secs vs.  
235±61secs, p=0.1), however, there was a significant difference in the clot elasticity at the 
GP (G’GP) results (0.032±0.010Pa vs.  0.046±0.016Pa, p=0.01) (see Fig 1).  Venous plasma 
noradrenaline concentration increased in all volunteers following tyramine infusion (1.8±0.7 
vs.  10.0±4.6, p>0.001). Leg blood flow (393±156mL/min vs.  81±66mL/min, p=0.001) and 
LVC (4.8±2.1mL/min/mmHg vs.  1.0±0.8mL/min/mmHg, p=0.001) were both reduced 
following tyramine infusion.  In addition, tyramine infusion induced an increase in the mean 
arterial and venous pressures of all participants: MAP from 84.9±4.4mmHg to 
88.0±5.2mmHg (p=0.001) and CVP from 3.7±1.6mmHg to 4.2±1.6mmHg (p=0.001).  There 
were no significant changes in any of the standard laboratory markers between pre- and 
post- tyramine infusion (Table 1).  
Effect of exercise with a small muscle mass on clot structure: Following moderate intensity 
knee extensor exercise there was an increase in df in the venous samples (from 1.688±0.025 
to 1.723±0.023, p=0.001). There was a decrease in the clotting time measurement of the GP 
(TGP) (240 ± 76 secs vs.  204 ± 41 secs, p=0.01), and an increase in the clot elasticity at the 
GP (G’GP) results ( 0.03 ± 0.01 Pa vs. 0.04 ± 0.02 Pa, p=0.01) (Fig 2).  We found no significant 
changes between pre and post exercise in any of the standard laboratory markers of 
coagulation. Results for the pre and post knee extensor exercise experiment can be seen in 
Table 2. When comparing the venous results to the arterial results we found no difference in 
the samples before exercise (venous: df = 1.688±0.025 vs arterial: df = 1.694±0.031) or in 
the post exercise samples (venous: 1.723±0.023 vs arterial: df = 1.721±0.035). No difference 
was detected for all of the other parameters tested (TGP and G’GP). 
 
 
  
 Figure 1: The effect of tyramine infusion on the rheological parameters of the gel point. 
This figure shows the change in the viscoelastic parameters for 12 healthy volunteers pre 
and post infusion with 1.0 µmol · min-1 · L leg volume-1 of Tyramine. * denotes a 
significant change with a p<0.05, ** denotes a significant change with a p<0.01. 
 
  
Table 1: Table showing results of the physiological measures for pre and post Tyramine 
infusion. This Table shows the change in the physiological parameters for 12 healthy 
volunteers pre and post infusion with 1.0 µmol · min-1 · L leg volume-1 of Tyramine. 
  Pre Tyramine Post Tyramine Significance 
LEG BLOOD FLOW 
(mL/min) 
393 ± 156 81 ± 66 0.001  
MAP (mmHg) 85.5 ± 5.2 88.5 ± 5.2 0.001  
CVP (mmHg) 3.7 ± 1.7 4.2 ± 1.6  0.001 
LVC 
(mL/min/mmHg) 
4.8 ± 2.1 1.0 ± 0.8 0.001  
NOREPINEPHRINE 
(nmol/L) 
1.8 ± 0.7 10.0 ± 4.6 0.001  
 
 
  
Table 2: Table showing results of the standard laboratory markers for the Tyramine and 
single leg exercise experiments. This figure shows the change in the laboratory markers for 
12 healthy volunteers pre and post infusion with 1.0 µmol · min-1 · L leg volume-1 of 
Tyramine and pre and post single leg knee extensor exercise. 
 
 APTT (s) Pt-time (s) 
Fibrinogen 
(µmol/L) 
Pre Tyramine 32.9 ± 6.3 24.4 ± 1.5 7.0 ± 0.7 
Post Tyramine 30.6± 2.5 (NS) 24.8 ± 1.4 (NS) 6.8 ± 0.7 (NS) 
Pre Exercise 32.8 ± 9.3 24.4 ± 1.5 7.3 ± 0.8 
Post Exercise 32.3± 8.0 (NS) 24.0 ± 1.2 (NS) 7.6 ± 0.5 (NS) 
(NS is an indication no significant change) 
 
  
 Figure 2: The effect of exercise on the rheological parameters of the gel point. This figure 
shows the change in the viscoelastic parameters for 12 healthy volunteers pre and post 
single leg knee extensor exercise. * denotes a significant change with a p<0.01, ** denotes 
a significant change with a p<0.001. 
  
Discussion  
It has been reported that exercise influences the balance in coagulation in normal subjects 
and also in patients with an increased risk of  thrombo-embolism.[24] In a previous study 
using the df biomarker to explore the systemic effect of exercise on coagulation we showed 
that, as exercise intensity was increased, so was the effect on coagulation.[5] Whereas 
exercise intensity was increased, the tendency was for the blood to produce clots with a 
significant increase in df indicating denser, more compact and mechanically stronger clot 
microstructures being produced. However, controversies exist concerning the mechanisms 
behind exercise induced alterations in the coagulation process. In the present study, we 
show for the first time that an experimentally induced increase in noradrenaline by intra-
arterial tyramine infusion results in denser more compact clot microstructures being 
produced as evidenced by an increase in df in healthy volunteers. By use of a small muscle 
mass exercise model we, moreover, show that exercise can influence clot microstructure 
most likely via a change in blood flow and thus shear. 
In the present study, we utilized femoral arterial tyramine infusion to induce a local 
noradrenaline release in the leg, amounting to a femoral venous concentration of ~10  
nmol/L. This concentration corresponds to plasma noradrenaline levels during moderate to 
high intensity cycling exercise.[25] The increase in noradrenaline in the present study was 
associated with a significant increase in the df value (Fig. 1). An increase in df corresponds to 
a more tightly packed, highly branched clot that is less permeable and stronger, clot 
characteristics that are associated with thromboembolic or hypercoagulable disease.[19-22] 
The magnitude of the change in df in this study is comparable to the change seen in healthy 
people pre and post aspirin.[22] Furthermore there was a significant increase in the G`GP 
value after tyramine infusion, a measure of clot elasticity/strength (Fig. 1). The results 
indicate that a physiologically relevant increase in noradrenaline in vivo produces a 
hypercoagulable effect in healthy volunteers. Interestingly, it has been shown previously in 
an in vitro study that catecholamines cause an increase in platelet activity.[26,27] This could 
be a possible rationale as to why in the present in vivo study catecholamine release induces 
this hypercoagulable effect. Unlike df, the measure for clotting time using viscoelastic 
analysis, TGP, did not change pre and post tyramine (p=0.34, Figure 1). This is also shown in 
the time based standard markers of coagulation PT and aPTT, both of which were not 
significantly altered (Table 1). This observation agrees with previous studies from our group, 
showing that rate based assessments of coagulation such as PT, aPTT and TGP are often 
insensitive to changes in coagulation induced by disease and treatment, unlike measures of 
clot microstructure and strength which do detect changes.[28,29].  Interestingly we found 
no difference in the viscoelastic measurements when comparing arterial and venous 
samples, suggesting that there is no difference in coagulability in blood between these two 
s=systems.  
In a previous study investigating the systemic effect of exercise we showed that a graded 
exercise program to exhaustion causes a hypercoagulable  response that results in an 
increase in clot microstructural properties as measured by the df biomarker.[5] To assess 
whether the previously observed effect of exercise on clot microstructure was caused by 
catecholamine release, we investigated the effect of moderate intensity knee extensor 
exercise which engages a small muscle mass (approx. 2.5 kg of muscle). Due to the small 
muscle mass recruited, this exercise form induces only a minor increase in sympathetic 
activity in young healthy individuals, as evidenced by small increases in plasma 
noradrenaline  and by minor increases in HR and MAP.[30-32] In contrast, local blood flow 
during moderate knee extensor exercise is markedly (~10 fold) increased leading to an 
enhanced level of  vascular shear stress.[33] We observed a smaller magnitude of change in 
df during knee extensor exercise when compared to the high intensity cycling exercise in the 
previous study (about half as large 0.03 vs 0.06).[5] Combined with the current finding that 
tyramine infusion results in an increase in the value of df, our results suggest that both 
noradrenaline and exercise related factor(s), including the increase in blood flow with 
consequent increases in vascular shear stress, contribute to changes in clot 
microstructure.[33] Additionally, it has previously been shown that the effect of acute 
exercise on platelet function depends on the intensity of the exercise, with only strenuous 
exercise temporarily increasing platelet reactivity and moderate exercise being shown to 
suppress platelet reactivity.[34-36] Therefore, whereas the acute high intensity cycling 
exercise trial in our previous study likely would have resulted in an increase in platelet 
reactivity, the small muscle mass moderate level exercise undertaken in this study would 
most likely not.[34-36]  
In this study we show for the first time how the systemic effect of increased levels of 
noradrenaline alters clot microstructure formation and can promote abnormal clot 
formation. In healthy people, abnormal clot formation and its progression is prevented by 
factors such as healthy endothelium, an effective fibrinolytic pathway, and other inhibitory 
and protective pathways in the blood. However, patients with arteriosclerotic disease such 
as myocardial infarction will have abnormal and damaged endothelium which leads to an 
altered blood flow pattern corresponding to a change in shear rate which promotes and 
enhances a hypercoagulable state.[16,20] In acute vascular disease these changes, in 
combination with catecholamine release, promote atherothrombotic risk. At present these 
changes have not been determined in either normal or abnormal vessel disease alongside 
both the intensity and long term risk of exercise. The present study has explored the 
mechanisms of blood flow, catecholamine release, and exercise to show that all these 
factors have potential to modify the coagulation status of the individual and alter clot 
quality. Considering these effects, particular caution should be taken in introducing high 
intensity exercise with large muscle mass for individuals at risk. Further work is now 
required to investigate the mechanisms linking catecholamine release to abnormal clot 
formation and determine the risk/benefit ratio in patients with aeropathic disease and its 
rehabilitation through exercise. 
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